FDA Staff Weighs In on Potential First mRNA Flu Shot
Ahead of an advisory committee meeting this week, FDA reviewers raised no serious efficacy or safety concerns about Moderna's mRNA ...
Ahead of an advisory committee meeting this week, FDA reviewers raised no serious efficacy or safety concerns about Moderna's mRNA ...
Health Secretary Robert F. Kennedy Jr. this week refused to release a cruise ship passenger exposed to hantavirus in early ...
Legal and public health experts expressed concern about HHS Secretary Robert F. Kennedy Jr.'s scrutiny of a medical journal's decision ...
A long-term study of adults with prediabetes showed that lifestyle changes were tied to a lower risk of multimorbidity, but ...
The FDA informed healthcare providers about disruptions in the supply of stereotactic breast biopsy needles that will likely persist through ...
The American Academy of Pediatrics (AAP) pushed back on HHS Secretary Robert F. Kennedy Jr.'s claims that the CDC's vaccine ...
CHICAGO -- A multidisciplinary group of menopause experts developed new comorbidity-specific guidance on non-hormone therapy for moderate-to-severe vasomotor symptoms. For ...
An older Japanese American woman with advanced Alzheimer's disease experienced transient improvements in multiple domains after taking psilocybin-containing mushrooms, according ...
I vividly remember my first day in outpatient clinic as an intern more than 30 years ago, when my patient ...
In the U.K., resident doctors in cardiology claimed it was not uncommon to observe physician assistants (PAs) performing actions outside ...
The FDA approved another opioid overdose reversal product for over-the-counter (OTC) use, the agency announced on Tuesday. The 4-mg intranasal ...
A massive wave of new prescriptions for GLP-1 receptor agonists is expected following the July launch of a Medicare pilot ...
At 10 years, TAVR with the second-generation balloon-expandable Sapien XT was associated with higher mortality and aortic valve reintervention than ...
At the American Society of Clinical Oncology (ASCO) meeting, updated HER2CLIMB-05 findings on the addition of tucatinib (Tukysa) to first-line ...
Two family medicine residency programs in the Seattle-Tacoma area are folding or downsizing, raising concerns about physician shortages in already ...
Looking back at the cheeses I ate as a kid, I mainly remember bright orange cheddar, monterey jack, and powdery ...
In contrast to concerns of lean mass loss with GLP-1 receptor agonists, a large population-based study found lower fracture rates ...
Neuroscientist Emily Rogalski is uncovering the secrets of superagersCraig Boylan As you age, your memory will likely decline. Your ability ...
Infant mortality in the U.S. dropped to a new all-time low in 2025, according to preliminary government data. There were ...
Several studies presented at this year's American Society of Clinical Oncology (ASCO) annual meeting highlighted emerging strategies for hormone receptor ...
| M | T | W | T | F | S | S |
|---|---|---|---|---|---|---|
| 1 | 2 | |||||
| 3 | 4 | 5 | 6 | 7 | 8 | 9 |
| 10 | 11 | 12 | 13 | 14 | 15 | 16 |
| 17 | 18 | 19 | 20 | 21 | 22 | 23 |
| 24 | 25 | 26 | 27 | 28 | 29 | 30 |
| 31 | ||||||
© 2022 NewsHealth.
© 2022 NewsHealth.